Hamamatsu Photonics K.k. · TSE:6965
Hamamatsu Photonics K.k — Q2 FY2021 Earnings Presentation
32 slides from Hamamatsu Photonics K.k's earnings presentation, May 14, 2021
Slide 1: Fiscal Year ending September 30, 2021 Second Quarter Report
Fiscal Year ending September 30, 2021 Second Quarter Report Hamamatsu Photonics K.K. Stock code 6965 May, 2021 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 1
Slide 2: Notes
Notes This material is not intended to be a solicitation to buy or sell any securities of Hamamatsu Photonics K.K. The information contained in this material is based on data available as of making it. No guarantees, promises are made as to its accuracy or completeness. This material includes
Slide 3: Summary of 1st half results; Annual forecast
1. Summary of 1st half results 2. Annual forecast 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 3
Slide 4: Summary of 1st half financial results
Summary of 1st half financial results Net sales are 79.3 billion yen (up by 8.7 % or +6.3 billion yen from last year). In addition to the recovery of the electronic components and semiconductor markets, the increase in demand for PCR testing related to the novel coronavirus infection (COVID-19) pu
Slide 5: Consolidated 1st half financial results
Consolidated 1st half financial results (Unit : Million Yen) Currency impact on net sales : -50 million yen Compared with prev. year FY2020 FY2021 1st half 1st half Amount of Change rate Sales increase mainly in medical-bio instrument change and industry instrument applications. Net sales 72,975 79,
Slide 6: Analysis of operating profit from 1st half of FY2020 to 1st half of FY2021
Analysis of operating profit from 1st half of FY2020 to 1st half of FY2021 (Unit : Million Yen) *Excluding currency exchange effect Increase of gross Amount due to Change of SG & Impact by profit by sales change in gross 18,000 A and R & D currency increase profit ratio expenses fluctuation 3,197 (9
Slide 7: Sales by industry & application
Sales by industry & application Dental is still in the process of recovery, Markets of semiconductor manufacturing Decreased in oil well logging due to but other products have recovered. Special and FA recovered. sluggish crude oil production. demand for PCR testing to continue. Non-destructive insp
Slide 8: Consolidated financial results by business segment
Consolidated financial results by business segment (Unit : Million Yen) FY2019 FY2020 Amount of change Segment Account item / percent change Summary 1st half 1st half Medical-bio instrument and industrial instrument increased. Net sales 28,626 30,448 +1,882 …There was special demand for laboratory t
Slide 9: Sales by region
Sales by region Europe Asia and China Japan North America FY2020 23.1 % 24.6 % 26.8 % 25.3 % 1st half FY2021 1st half 23.0 % 26.7 % 26.8 % 23.3 % (Unit : Million Yen) Europe Asia (of which China) Japan North America FY2020 1st half 16,879 17,967 (11,624) 19,556 18,472 FY2021 1st half 18,276 21,179 (
Slide 10: Summary of 1st half results; Annual forecast
1. Summary of 1st half results 2. Annual forecast 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 10
Slide 11: Summary of FY2021 annual forecast
Summary of FY2021 annual forecast Upwardly revised forecast due to earlier than expected recovery in the 2nd half of the FY2021 and a change in the assumed exchange rate (weaker yen). Net sales and operating profit are expected to reach record highs. Net sales projection is 159 billion yen (up b
Slide 12: Sales & profit through FY2023
Sales & profit through FY2023 Sales (Unit : Million Yen) 180,000 160,000 140,000 120,000 100,000 80,000 60,000 40,000 20,000 0 FY2021 FY2021 FY2022 FY2023 FY2019 FY2020 (Original plan) (Forecast) (Plan) (Plan) Net sales 145,912 140,251 145,600 159,000 157,500 170,100 Operating profit 25,403 21,752 2
Slide 13: FY2021 annual forecast (comparison with previous year)
FY2021 annual forecast (comparison with previous year) (Unit : Million Yen) From previous year FY2020 FY2021 Currency impact on net sales : +0.1 billion yen. result (Forecast) Amount of Change change rate Net sales 140,251 159,000 +18,749 +13.4 % Sales increase mainly in medical-bio instrument and i
Slide 14: Sales forecast by industry & application (comparison with previous year)
Sales forecast by industry & application (comparison with previous year) In addition to normal demand for medical Recovery of semiconductor To continue weak demand for oil-well logging. equipment, demand for PCR testing to manufacturing and FA market. increase due to the COVID-19 pandemic. In additi
Slide 15: FY2021 annual forecast (comparison with original plan)
FY2021 annual forecast (comparison with original plan) (Unit : Million Yen) FY2021 From original plan Currency impact on net sales : +3.4 billion yen. FY2021 (Original Amount of Change (Forecast) plan) change rate Demand increase in various industries including Net sales 145,600 159,000 +13,400 +9.2
Slide 16: Sales forecast by industry & application (comparison with original plan)
Sales forecast by industry & application (comparison with original plan) Orders related to the COVID-19 Semiconductor manufacturing and FA Decline of oil-well logging to be less than expected. pandemic are higher than expected. market to recover more than expected. No significant change from origina
Slide 17: Consolidated financial forecast by business segment
Consolidated financial forecast by business segment (Unit : Million Yen) FY2020 FY2021 FY2021 comparison with comparison with Segment Account item Factors for changing the forecast result (Original plan) (Forecast) previous year original plan Medical-bio instrument and industrial instrument is Net s
Slide 18: Group locations in Asia, North America and Europe
Asia North America HAMAMATSU PHOTONICS K.K. HAMAMATSU CORPORATION Headquarters Main Office / California Office HAMAMATSU PHOTONICS (CHINA)Co., Ltd. PHOTONICS MANAGEMENT Corp. Head Office / Shanghai Branch / Shenzhen Branch ENERGETIQ TECHNOLOGY, Inc. BEIJING HAMAMATSU PHOTON TECHNIQUES INC. Head Offi
Slide 19: Second Quarter of Fiscal Year ending September 30, 2021 Databook
Second Quarter of Fiscal Year ending September 30, 2021 Databook Hamamatsu Photonics K.K. Tokyo Stock Exchange : 6965 5.14. 2021 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 19
Slide 20: Notes
Notes This material is not intended to be a solicitation to buy or sell any securities of Hamamatsu Photonics K.K. The information contained in this material is based on data available as of making it. No guarantees, promises are made as to its accuracy or completeness. This material includes
Slide 21: Consolidated income statements
Consolidated income statements (Unit : Million Yen) FY2019 FY2020 FY2021 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Net sales 145,912 100.0 72,975 67,276 140,251 100.0 79,342 79,658 159,000 100.0 Cost of sales 71,916 49.3 36,768 35,006 71,774 51.2 40,943 40,657 81
Slide 22: Consolidated sales by industry
Consolidated sales by industry (Unit : Million Yen) FY2019 FY2020 FY2021 Application 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Radiographic testing 40,841 28.0 22,366 17,800 40,166 28.6 21,523 21,653 43,176 27.2 Medical-bio Laboratory testing 14,420 9.9 6,771 8,0
Slide 23: Sales by industry & application Electron tube segment
Sales by industry & application Electron tube segment (Unit : Million Yen) FY2019 FY2020 FY2021 Application 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Radiographic testing 11,239 18.9 5,874 4,482 10,356 19.0 4,794 4,804 9,598 15.7 Medical-bio Laboratory testing 8,
Slide 24: Sales by industry & application Opto-semiconductor segment
Sales by industry & application Opto-semiconductor segment (Unit : Million Yen) FY2019 FY2020 FY2021 Application 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Radiographic testing 29,564 44.8 16,481 13,317 29,798 44.7 16,726 16,847 33,573 46.1 Medical-bio Laboratory
Slide 25: Sales by industry & application Imaging and measurement instruments segment
Sales by industry & application Imaging and measurement instruments segment (Unit : Million Yen) FY2019 FY2020 FY2021 Application 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Radiographic testing 3 0.0 7 0 7 0.0 0 0 0 0.0 Medical-bio Laboratory testing 3,650 19.8 1,
Slide 26: Major subsidiaries income statements (The U.S., Germany, China)
Major subsidiaries income statements (The U.S., Germany, China) Local currency (thousand dollar) Yen (million yen) Account FY2020 FY2021 FY2020 FY2021 Company item 2nd half Year 2nd half Year 1st half 2nd half Year % 1st half (Forecast) % 1st half 2nd half Year 1st half (Forecast) (Forecast) (Foreca
Slide 27: Consolidated financial forecast by business segment
Consolidated financial forecast by business segment (Unit : Million Yen) FY2019 FY2020 FY2021 Segment 2nd half Year Year 1st half 2nd half Year 1st half ％ (Forecast) (Forecast) Electron tube 59,593 28,626 26,010 54,636 30,448 30,552 61,000 38.4 Opto-semiconductor 66,006 35,219 31,447 66,666 36,764 3
Slide 28: Electron tube's consolidated performance
Electron tube's consolidated performance (Unit : Million Yen) FY2019 FY2020 FY2021 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Net sales 59,593 100.0 28,626 26,010 54,636 100.0 30,448 30,552 61,000 100.0 Cost of sales 25,491 42.8 12,082 11,237 23,319 42.7 13,231 13
Slide 29: Opto-semiconductor's consolidated performance
Opto-semiconductor's consolidated performance (Unit : Million Yen) FY2019 FY2020 FY2021 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Net sales 66,006 100.0 35,219 31,447 66,666 100.0 36,764 36,136 72,900 100.0 Cost of sales 35,913 54.4 19,837 18,289 38,126 57.2 21,5
Slide 30: Imaging and measurement instrument's consolidated performance
Imaging and measurement instrument's consolidated performance (Unit : Million Yen) FY2019 FY2020 FY2021 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Net sales 18,412 100.0 8,110 8,644 16,754 100.0 10,432 11,318 21,750 100.0 Cost of sales 9,247 50.2 4,016 4,485 8,501
Slide 31: Consolidated capital investments, R & D expenses and depreciation
Consolidated capital investments, R & D expenses and depreciation (Unit : Million Yen) FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 Rate to Rate to Rate to Rate to Rate to Rate to Amount Amount Amount Amount Amount Amount sales (%) sales (%) sales (%) sales (%) sales (%) sales (%) 1st quarter 1,441 4.8
Slide 32: 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved.
🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 32
Hamamatsu Photonics K.K. — Q2 FY2021 Earnings Presentation on 6ix